COLL vs WBD · P/E 17, rev $181.9M vs rev $39.32B
Collegium Pharmaceutical Inc (COLL) versus Warner Bros Discovery Inc (WBD) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Warner Bros Discovery Inc (WBD) is a entertainment company listed on NASDAQ.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported WBD revenue for 2024-12-31 was $39.32B. Net income was -$11.48B. Revenue was down 4.8% from 2023-12-31 to 2024-12-31. WBD currently screens at market cap $66.93B.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. WBD currently screens at market cap $66.93B.
Not investment advice. Open the COLL and WBD stock pages for the full models.
Not investment advice.